Milad Nazarzadeh
DPHIL STUDENT
Milad Nazarzadeh is DPhil student at the University of Oxford with a scholarship from the British Heart Foundation. His project focuses on the effect of blood pressure-lowering drugs and drug-drug interactions on the risk of type 2 diabetes through integrating epidemiologic and genetic data, supervised by Prof Kazem Rahimi, Dr Dexter Canoy, Dr Abbas Dehghan, Dr Derrick Bennett and Prof George Davey Smith.
Milad completed his BSc of Public Health at the Zanjan University of Medical Sciences, Iran, then received his MSc of Epidemiology from Shahid Beheshti University of Medical Science, Tehran, Iran. He was faculty member, lecturer and research director at University of Medical Sciences, Iran (Sabzevar and Torbat Heydarieh, 2015- 2017). Then, he joined The George Institute for Global Health, UK at the University of Oxford as Epidemiologist (2017-2019). Also, he is currently Associate Editor of the BMC Cardiovascular Disorders. His research interests include blood pressure, cardiovascular disease and Pharmacogenetics, using methodologies such as systematic review and meta-analysis, advanced statistical modelling, individual-patient meta-analysis and Mendelian Randomisation.
Recent publications
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570
-
Antihypertensive treatment and risk of cancer: Individual participant data meta-analysis of randomized clinical trials
Journal article
CANOY D. et al, (2021), The Lancet Oncology
-
Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: A Mendelian randomization study
Journal article
NAZARZADEH LARZJAN M. et al, (2021), Genome Medicine
-
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Journal article
Roth GA. et al, (2020), Journal of the American College of Cardiology, 76, 2982 - 3021
-
Blood pressure lowering treatment for prevention of cardiovascular events in patients with atrial fibrillation: an individual-participant data meta-analysis
Conference paper
Pinho-Gomes AC. et al, (2020), EUROPEAN HEART JOURNAL, 41, 672 - 672
-
Cardiometabolic disease, comorbidities and risk of death: findings using data from large-scale electronic health records
Conference paper
Canoy D. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2848 - 2848
-
Effect of blood pressure lowering treatment on the risk of atrial fibrillation: an individual-participant data meta-analysis
Conference paper
Pinho-Gomes AC. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2771 - 2771
-
Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation
Conference paper
Nazarzadeh M. et al, (2020), EUROPEAN HEART JOURNAL, 41, 469 - 469
-
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study
Conference paper
Nazarzadeh M. et al, (2020), EUROPEAN HEART JOURNAL, 41, 1990 - 1990
-
Stratified effects of blood pressure-lowering treatment on long-term blood pressure: an individual patient-level meta-analysis involving 50 randomised trials and 334,219 participants
Conference paper
Canoy D. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2762 - 2762
